NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo

NEO412 effectively killed melanoma cells In vitro, including TMZ-resistant and BRAF mutant ones, through DNA alkylation and subsequent apoptosis and In vivo, NEO412 inhibited tumor growth when applied topically to the skin of tumor-bearing animals.


Comments are closed.